• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经典补体途径成分在琼脂糖平板中的溶血试验:替代途径的干扰

Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.

作者信息

Martin A, Lachmann P J

出版信息

Clin Exp Immunol. 1977 Jan;27(1):13-22.

PMID:321155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1540905/
Abstract

It has been observed that when serum C6 is measured by the haemolytic radial diffusion technique a heat labile factor limits the size of the haemolytic rings. This reduction is haemolysis has been shown to be due to alternative pathway activation of C6 in the agarose plate; and that the heat labile factor is Factor B of the alternative pathway. This phenomenon is of practical importance when assaying for C6; however, it does not explain the observations of a C6 inactivator reported by Nelson & Biro (1968).

摘要

据观察,当采用溶血放射状扩散技术测定血清C6时,一种热不稳定因子会限制溶血环的大小。溶血的这种减少已被证明是由于琼脂糖平板中C6的替代途径激活所致;并且这种热不稳定因子是替代途径的B因子。在检测C6时,这一现象具有实际重要性;然而,它并不能解释Nelson和Biro(1968年)报道的C6灭活剂的观察结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/c02d0135f0d3/clinexpimmunol00239-0024-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/f4fc2f440837/clinexpimmunol00239-0023-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/5e6b39e11c5d/clinexpimmunol00239-0024-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/c02d0135f0d3/clinexpimmunol00239-0024-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/f4fc2f440837/clinexpimmunol00239-0023-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/5e6b39e11c5d/clinexpimmunol00239-0024-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e8/1540905/c02d0135f0d3/clinexpimmunol00239-0024-b.jpg

相似文献

1
Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.经典补体途径成分在琼脂糖平板中的溶血试验:替代途径的干扰
Clin Exp Immunol. 1977 Jan;27(1):13-22.
2
The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.C5b-9复合物:经典途径和替代途径产生的复合物的亚基组成。
J Immunol. 1976 May;116(5):1431-4.
3
Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.人初乳中的补体系统:人初乳中存在九种补体成分及替代途径因子。
Int Arch Allergy Appl Immunol. 1977;54(5):428-33.
4
Complement levels in normal and inflamed aqueous humor.正常及炎性房水中的补体水平。
Invest Ophthalmol Vis Sci. 1983 Mar;24(3):380-4.
5
Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.人腹膜巨噬细胞。活性末端补体成分C5至C9在体外的产生及补体的功能性替代途径。简报。
APMIS. 1988 Jan;96(1):89-92.
6
Serum lipoproteins and C567-INH activity.血清脂蛋白与C567 - 抑制物活性。
J Immunol. 1977 Sep;119(3):883-8.
7
Terminal complement components play a role in the expression of C5a.终末补体成分在C5a的表达中起作用。
J Immunol. 1987 Feb 1;138(3):838-41.
8
The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.与“反应者”状态相关的补体谱:产后即刻的一项研究
Clin Exp Immunol. 1978 Mar;31(3):419-25.
9
Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.与肾炎相关的遗传性补体第七成分缺乏。形成C56及相关C7消耗活性的倾向。
J Clin Invest. 1978 Jun;61(6):1602-10. doi: 10.1172/JCI109080.
10
Cyanate as an inactivator of complement proteins.氰酸盐作为补体蛋白的一种灭活剂。
J Immunol. 1975 Dec;115(6):1558-65.

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b, and c, essential for haemolysis.豚鼠补体第三成分的多重性质。I. 溶血所必需的三种因子a、b和c的分离与特性鉴定。
Immunology. 1965 Jun;8(6):590-603.
3
Complement components of a haemolytically deficient strain of rabbits.
溶血缺陷型兔的补体成分。
Immunology. 1968 Apr;14(4):527-40.
4
The quantitation of C6 in rabbit and human sera.兔血清和人血清中C6的定量分析。
Clin Exp Immunol. 1971 Sep;9(3):359-70.
5
Selective enzyme purification by affinity chromatography.通过亲和色谱法进行选择性酶纯化。
Proc Natl Acad Sci U S A. 1968 Oct;61(2):636-43. doi: 10.1073/pnas.61.2.636.
6
Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.关于抑制C56起始裂解(反应性裂解)的研究。II. C567-INH——补体C567三分子复合物的一种抑制剂。
Int Arch Allergy Appl Immunol. 1974;47(4):623-32. doi: 10.1159/000231255.
7
Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.关于C56起始裂解(反应性裂解)抑制作用的研究。I. 现象描述及测定方法。
Immunology. 1974 Jun;26(6):1145-57.
8
The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.通过胃蛋白酶消化抗原-抗体沉淀物将特异性抗体纯化为F(ab')2及其在免疫球蛋白和补体抗原中的应用。
Immunochemistry. 1971 Jan;8(1):81-8. doi: 10.1016/0019-2791(71)90423-x.
9
Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.关于C56启动的溶解(反应性溶解)抑制作用的研究。III. C567-INH抑制活性的特性及其作用方式。
Immunology. 1975 Jan;28(1):133-49.
10
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.补体激活替代途径中B因子和D因子的溶血扩散平板试验。
Immunochemistry. 1976 Apr;13(4):317-24. doi: 10.1016/0019-2791(76)90341-4.